EuroIntervention PCRonline - Connecting with the community

George D. Dangas

13 articles

Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention

EuroIntervention 2017;12:1757-1765 published online November 2016

Published in Volume 12 Number 14, February 2017

Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: insights from the HORIZONS-AMI trial

EuroIntervention 2016;12:1144-1153

Published in Volume 12 Number 9, October 2016

Effects of baseline and early acquired thrombocytopaenia on long-term mortality in patients undergoing percutaneous coronary intervention with bivalirudin

EuroIntervention 2016;11:e1627-e1638 published online e-edition April 2016

Published in Volume 11 Number 14, April 2016

Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index

EuroIntervention 2015;11:634-642 published online ahead of print October 2014

Published in Volume 11 Number 6, October 2015

Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to “mega centre” for patients with ST-segment elevation myocardial infarction

EuroIntervention 2015;11:503-510 published online ahead of print November 2014

Published in Volume 11 Number 5, September 2015

Stroke prevention in valvular heart disease: from the procedure to long-term management

EuroIntervention 2015;11:W26-W31

Published in Volume 11 Supplement W, September 2015

Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty

EuroIntervention 2014;10:312-319 published online ahead of print November 2013

Published in Volume 10 Number 3, July 2014

Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials

EuroIntervention 2014;10:97-104 published online ahead of print September 2013

Published in Volume 10 Number 1, May 2014

Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial

EuroIntervention 2013;9:220-227

Published in Volume 9 Number 2, June 2013

Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial

EuroIntervention 2013;8:1033-1039

Published in Volume 8 Number 9, January 2013

Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial

EuroIntervention 2011;7:905-916

Published in Volume 7 Number 8, December 2011

Clinical utility of biomarkers to predict major bleeding events after STEMI: a Horizons-AMI substudy with 3-year follow-up

Published in Volume 7 Supplement M, May 2011

Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials

EuroIntervention 2009;5:475-484

Published in Volume 5 Number 4, September 2009